Harvard Early Detection and Interception of Cancer Current Practice Recommendations and Novel Emerging Approaches 2025 (Videos)

Description

Include: 1 videos, size: GB

Target Audience: oncologists, primary care physicians

Information:

Elevate your approach to cancer prevention with this dynamic course offering practical guidance on current screening practices, management of high-risk populations, and the integration of emerging early detection technologies into clinical care.

Through this course we will provide a comprehensive review of current cancer screening guidelines, provide guidance regarding high-risk populations and their management, educate regarding emerging technologies for early cancer detection, and provide referral pathways for complex patients.

Learning Objectives

Identify and implement current cancer screening guidelines, with a focus on early detection and intervention for high-risk populations, and provide recommendations for managing these patients.
Identify and establish appropriate referral pathways for patients with pre-malignant conditions requiring specialized care.
Evaluate emerging technologies in cancer detection and assess their application for early detection of cancer.

Harvard’s “Early Detection and Interception of Cancer: Current Practice Recommendations and Novel Emerging Approaches” 2025 is best for clinicians, researchers, and healthcare professionals focused on cancer prevention, screening, and early intervention.

Here’s a detailed breakdown of who benefits most and what the program offers:

👩‍⚕️ Who Should Attend

Primary care physicians and oncologists: To stay updated on best practices for cancer screening and risk management.
Genetic counselors and specialists: To understand how emerging technologies impact hereditary cancer risk assessment.
Medical researchers and public health professionals: To explore novel biomarkers, AI-driven diagnostics, and population-level strategies.
Healthcare administrators and policy makers: To evaluate integration of new screening tools into clinical workflows and health systems.
Advanced practice providers (NPs, PAs): To enhance their role in early detection and patient education.

🧬 What You’ll Learn

Current screening guidelines for major cancers (e.g., breast, colorectal, lung).
Management of high-risk populations, including those with genetic predispositions.
Emerging technologies such as liquid biopsies, AI-powered imaging, and molecular diagnostics.
Strategies for clinical integration of new tools and approaches into routine care.

+ Topics:

Monday, September 15, 2025

9:00-9:15 am Welcome and Kick Off Ben Ebert; Sapna Syngal; Betsy O’Donnell
9:15-9:45 am Whole Body Imaging for Screening and Early Detection of Cancer – Promises and Pitfalls Michael Rosenthal
9:45-10:00 am Management of DCIS (Ductal Carcinoma in SITU) and Other Breast Cancer Precursors Emily Gatof
10:00-10:15 am Genetics 101: Identification and Genetic Testing for Inherited Cancer Predisposition Elizabeth Kearns
10:15-10:30 am Management of Hereditary Cancer Predisposition in Your Practice Huma Rana
10:30-10:45 am Screening and Early Detection of Gynecologic Malignancies Colleen Feltmate
10:45-11:00 am Q&A Colleen Feltmate; Emily Gatof; Huma Rana; Elizabeth Kearns
11:00-11:15 am Break
11:15-11:30 am Screening and Early Detection of Dermatologic Malignancies Nicole Leboeuf
11:30-11:45 am Unexplained Cytopenia – When to Consider Clonal Hematopoiesis and Myelodysplastic Syndrome (MDS) Lachelle Weeks
11:45 am-12:00 pm Intercepting Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma Irene Ghobrial
12:00-12:15 pm Q&A Nicole Leboeuf; Lachelle Weeks; Irene Ghobrial
12:15-1:00 pm Lunch Break
1:00-1:15 pm Precursors to Head & Neck, Oral Cancers, and Management Glenn Hanna
1:15-1:30 pm Management of IPMNs, Barrett’s Esophagus and other Precursors to GI Cancer Nicolette Rodriguez
1:30-1:45 pm Screening and Early Detection of Lung Cancer Jacob Sands
1:45-2:00 pm Screening and Early Detection of Genitourinary Cancers Bicky Thapa
2:00-2:15 pm Q&A Nicolette Rodriguez; Jacob Sands; Glenn Hanna; Bicky Thapa
2:15-2:30 pm Break
2:30-2:45 pm Multi-Cancer Early Detection Tests – Ready for Prime Time? Betsy O’Donnell
2:45-3:00 pm Promoting Equity in Screening and Early Detection Timothy Rebbeck
3:00-3:15 pm Patient Experience with Multi-Cancer Early Detection Testing Karen Burns White
3:15-3:30 pm Panel Discussion: Looking to the Future of Early Detection and Interception Betsy O’Donnell; Timothy Rebbeck; Karen Burns White; Sapna Syngal
3:30-4:30 pm Networking Reception